Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literature
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background: Omega-3 (n-3) fatty acid supplementation is becoming increasingly popular. However given its antithrombotic properties the potential for severe adverse events (SAE) such as bleeding has safety implications, particularly in an older adult population. A systematic review of randomized control trials (RCT) was conducted to explore the potential for SAE and non-severe adverse events (non-SAE) associated with n-3 supplementation in older adults. Methods: A comprehensive search strategy using Medline and a variety of other electronic sources was conducted. Studies investigating the oral administration of n-3 fish oil containing eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) or both against a placebo were sourced. The primary outcome of interest included reported SAE associated with n-3 supplementation. Chi-square analyses were conducted on the pooled aggregate of AEs. Results: Of the 398 citations initially retrieved, a total of 10 studies involving 994 older adults aged ≥60 years were included in the review. Daily fish oil doses ranged from 0.03 g to 1.86 g EPA and/or DHA with study durations ranging from 6 to 52 weeks. No SAE were reported and there were no significant differences in the total AE rate between groups (n-3 intervention group: 53/540; 9.8%; placebo group: 28/454; 6.2%; p = 0.07). Non-SAE relating to gastrointestinal (GI) disturbances were the most commonly reported however there was no significant increase in the proportion of GI disturbances reported in participants randomized to the n-3 intervention (n-3 intervention group: 42/540 (7.8%); placebo group: 24/454 (5.3%); p = 0.18). Conclusions: The potential for AEs appear mild-moderate at worst and are unlikely to be of clinical significance. The use of n-3 fatty acids and the potential for SAE should however be further researched to investigate whether this evidence is consistent at higher doses and in other populations. These results also highlight that well-documented data outlining the potential for SAE following n-3 supplementation are limited nor adequately reported to draw definitive conclusions concerning the safety associated with n-3 supplementation. A more rigorous and systematic approach for monitoring and recording AE data in clinical settings that involve n-3 supplementation is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525 · cited 1×
“Despite many reviews concentrating on the efficacy of n-3 fatty acids in various conditions [16-20], the potential for serious adverse events (SAE) is not well documented, particularly in older adults.”
BackgroundFish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits
Mozaffarian, D., & Rimm, E. B. (2006) · JAMA · doi:10.1001/jama.296.15.1885 · Cited by 1,966
Wang, C., Harris, W. S., Chung, M., Lichtenstein, A. H., Balk, E. M., Kupelnick, B., Jordan, H. S., & Lau, J. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.5 · Cited by 980
Polyunsaturated fatty acids, inflammation, and immunity
Calder, P. C. (2001) · Lipids · doi:10.1007/s11745-001-0812-7 · Cited by 784
Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751
Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale
Calder, P. C. (2009) · Biochimie · doi:10.1016/j.biochi.2009.01.008 · Cited by 721 · cited 1×
“Background There is evidence for benefits of long chain omega-3 (n-3) fatty acids in pathological inflammation [1] including rheumatoid arthritis [2], crohn’s disease [3], ulcerative colitis [4,5], diabetes mellitus [6], cardiovascular events [7-9] and cancer cachexia [10].”
BackgroundHooper, L., Thompson, R. L., Harrison, R. A., Summerbell, C. D., Ness, A. R., Moore, H. J., Worthington, H. V., Durrington, P. N., Higgins, J. P. T., Capps, N. E., et al. (2006) · BMJ · doi:10.1136/bmj.38755.366331.2f · Cited by 676 · cited 1×
“Background There is evidence for benefits of long chain omega-3 (n-3) fatty acids in pathological inflammation [1] including rheumatoid arthritis [2], crohn’s disease [3], ulcerative colitis [4,5], diabetes mellitus [6], cardiovascular events [7-9] and cancer cachexia [10].”
BackgroundSmith, G. I., Atherton, P., Reeds, D. N., Mohammed, B. S., Rankin, D., Rennie, M. J., & Mittendorfer, B. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005611 · Cited by 665 · cited 4×
“Four authors [31,33,36,45] who responded via email correspondence reported no additional AEs than those initially presented in the full-text article.”
BackgroundInfluentialBenefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis
Eslick, G. D., Howe, P. R. C., Smith, C., Priest, R., & Bensoussan, A. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.03.092 · Cited by 299 · cited 1×
“For example, there are some concerns raised over the potential adverse effect on LDL-cholesterol and the subsequent increased susceptibility to oxidation following n-3 supplementation [49-52].”
BackgroundThies, F., Miles, E. A., Nebe‐von‐Caron, G., Powell, J. R., Hurst, T. L., Newsholme, E. A., & Calder, P. C. (2001) · Lipids · doi:10.1007/s11745-001-0831-4 · Cited by 279 · cited 6×
“…de Rest et al. 2008 [37] d Van de Rest et al. 2008 [38] Querques et al. 2009 [41] 72.7 0.72 g/d EPA; 0.48 g/d DHA Usual care 26 weeks 38 Unclear a Thies et al. 2001 [31] 55-75 0.7 g/d DHA; OR 0.72 g/d EPA; 0.28 g/d DHA α-linolenic acid, γ-linolenic acid, OR arachidonic acid 12 weeks 46 Capsules…”
BackgroundMethodInfluential
Cited by
Ezekowitz, J. A., O'Meara, E., McDonald, M. A., Abrams, H., Chan, M., Ducharme, A., Giannetti, N., Grzeslo, A., Hamilton, P. G., Heckman, G. A., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.022 · Cited by 676
Cosmetic and Therapeutic Applications of Fish Oil’s Fatty Acids on the Skin
Huang, T.-H., Wang, P.-W., Yang, S.-C., Chou, W.-L., & Fang, J.-Y. (2018) · Marine Drugs · doi:10.3390/md16080256 · Cited by 210
“The PUFAs in fish oils have proved to be beneficial for treating rheumatoid arthritis, psoriasis, ulcerative colitis, asthma, Parkinson’s disease, osteoporosis, diabetes mellitus, cardiovascular events, cancers, and depression [4].”
BackgroundSenftleber, N., Nielsen, S., Andersen, J., Bliddal, H., Tarp, S., Lauritzen, L., Furst, D., Suarez-Almazor, M., Lyddiatt, A., & Christensen, R. (2017) · Nutrients · doi:10.3390/nu9010042 · Cited by 114
Chang, C.-H., Tseng, P.-T., Chen, N.-Y., Lin, P.-C., Lin, P.-Y., Chang, J. P. C., Kuo, F.-Y., Lin, J., Wu, M.-C., & Su, K.-P. (2018) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.01.001 · Cited by 103
Itsiopoulos, C., Marx, W., Mayr, H. L., Tatucu-Babet, O. A., Dash, S. R., George, E. S., Trakman, G. L., Kelly, J. T., Thomas, C. J., & Brazionis, L. (2018) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2018.02.002 · Cited by 37
Metadata
- Authors
- Villani, A. M., Crotty, M., Cleland, L. G., James, M. J., Fraser, R. J., Cobiac, L., & Miller, M. D.
- Venue
- BMC Geriatrics
- Published
- 2013-05-01
- Volume
- 13
- Issue
- 1
- Pages
- 41-41
- ISSN
- 1471-2318 (ISSN-L)
- OpenAlex
- W2160064198
- Cited by
- 41
- References
- 12
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literature. https://app.cochat.ai/papers/10.1186/1471-2318-13-41
- The paper
- Villani, A. M., Crotty, M., Cleland, L. G., James, M. J., Fraser, R. J., Cobiac, L., & Miller, M. D. (2013). Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literature. BMC Geriatrics. https://doi.org/10.1186/1471-2318-13-41
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.